• Title of article

    Recent trends in diagnosis and treatment of Clostridium difficile in a tertiary care facility

  • Author/Authors

    Sonia A. Butterworth، نويسنده , , Erik Koppert، نويسنده , , K. Alison Clarke-Stewart، نويسنده , , Barry Wiggs، نويسنده , , John K. MacFarlane، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 1998
  • Pages
    5
  • From page
    403
  • To page
    407
  • Abstract
    background With the prevalence of antibiotic use, the diagnosis and management of Clostridium difficile disease requires assessment. methods In a retrospective review, patients with a positive culture, toxin, or both during 1 year were identified. Recent literature was reviewed. Results of culture and toxin, prior antibiotic use, antibiotic treatment history and cost were analyzed. results Of 592 patients tested, 101 were positive; 96 of 101 were available for review. Of those positive tested for both, 45% were positive for toxin and culture. Sixty-two of 96 were treated with antibiotics; metronidazole was used in 90%. Ten of 62 antibiotic treatments were changed (mean 3 days). Ten days of metronidazole is 1/200th the cost of vancomycin. conclusions In 55% of the positive cases in which culture and toxin were obtained, one test was negative. As metronidazoleʹs efficacy and cost compares favorably with vancomycin, metronidazole is the drug of choice. Any changes made to antibiotic regimens occurred prior to the 6 days recommended in the literature.
  • Journal title
    The American Journal of Surgery
  • Serial Year
    1998
  • Journal title
    The American Journal of Surgery
  • Record number

    620291